|1.||Mrowietz, Ulrich: 11 articles (01/2014 - 12/2003)|
|2.||Thio, H B: 7 articles (03/2015 - 08/2003)|
|3.||Reich, Kristian: 6 articles (01/2016 - 03/2007)|
|4.||Gold, Ralf: 6 articles (08/2015 - 03/2008)|
|5.||Mrowietz, U: 6 articles (10/2014 - 02/2001)|
|6.||Balak, D M W: 5 articles (03/2015 - 06/2013)|
|7.||Altmeyer, P: 5 articles (05/2014 - 01/2003)|
|8.||Gambichler, Thilo: 4 articles (01/2016 - 03/2002)|
|9.||Gambichler, T: 4 articles (05/2014 - 01/2003)|
|10.||Werfel, T: 4 articles (10/2012 - 12/2003)|
|1.||Psoriasis (Pustulosis Palmaris et Plantaris)
02/01/2010 - "Fumaric acid esters (FAE) are used in Germany as a first-line systemic treatment for chronic plaque psoriasis, with proven efficacy and low toxicity. "
12/01/2011 - "Our successful therapy consisted of fumaric acid esters according to the therapeutic schedule for psoriasis and showed a good tolerance subjectively and objectively."
09/01/1999 - "We report the successful clearance of severe chronic plaque psoriasis following treatment with fumaric acid esters (FAE) in two patients who had failed previous systemic therapy. "
01/01/2006 - "The major conclusions from the results of medical RCT on moderate and severe psoriasis vulgaris are: Oral fumarates are effective in the treatment of moderate to severe psoriasis vulgaris. "
06/01/2014 - "Fumaric acid esters (FAEs) are effective in patients with moderate to severe psoriasis. "
06/01/2005 - "Recently, in several case reports, fumaric acid esters (FAE) have proved beneficial in granulomatous skin diseases, but studies on a larger collection of consecutive patients have not yet been performed. "
06/01/2005 - "Therapy of noninfectious granulomatous skin diseases with fumaric acid esters."
07/01/2006 - "Fumaric acid esters (FAE) have proven their therapeutic efficacy in psoriasis, a Th1 mediated skin disease. "
02/01/2004 - "Psoriasis vulgaris, a type-1 cytokine-mediated chronic skin disease, can be treated successfully with fumaric acid esters (FAE). "
11/01/2012 - "According to this data, fumarates may represent a new approach in the treatment of granulomatous and inflammatory skin diseases other than psoriasis vulgaris. "
01/01/2005 - "Treatment of granuloma annulare with fumaric acid esters (FAE) has recently been reported to be effective in 2 patients. "
05/01/2013 - "Successful treatment of disseminated granuloma annulare with oral fumaric acid esters."
01/01/2009 - "Low-dose fumaric acid esters significantly improve disseminated granuloma annulare in approximately 63% of patients. "
01/01/2009 - "Disseminated granuloma annulare has also been reported to respond to fumaric acid esters. "
01/01/2008 - "The literature on fumaric acid esters in granuloma annulare is reviewed."
|4.||Sarcoidosis (Schaumann Disease)
01/01/2014 - "The present case and similar reports in the literature highlight the probable efficacy of fumaric acid esters in the treatment of sarcoidosis and other non-infectious, granulomatous diseases."
01/01/2014 - "Multi-organ sarcoidosis treatment with fumaric acid esters: a case report and review of the literature."
06/01/2004 - "This case demonstrates a possible role for fumaric acid esters not only in the treatment of cutaneous but also systemic sarcoidosis."
12/24/2002 - "We report three patients with recalcitrant cutaneous sarcoidosis who were treated with oral fumaric acid esters (FAE). "
12/24/2002 - "Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters."
12/01/2014 - "Mode of action and clinical studies with fumarates in multiple sclerosis."
05/07/2010 - "Fumaric acid esters (FAE) are currently tested in clinical studies for their potential to treat multiple sclerosis. "
11/01/2008 - "Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies."
01/01/2011 - "Cytokine secretion pattern in treatment of lymphocytes of multiple sclerosis patients with fumaric acid esters."
06/01/2006 - "Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study."
|5.||Enteric-Coated Tablets (Tablets, Enteric Coated)
|6.||Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
|8.||citraconic acid (mesaconic acid)
|9.||Histamine (Histamine Dihydrochloride)
|1.||Photochemotherapy (Photodynamic Therapy)
|2.||Phototherapy (Light Therapy)